Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats

Kidney International

Volumn 64, Issue 3, 2003, Pages 887-896

  Nishino, Tomoya ^b   Miyazaki, Masanobu ^a   Abe, Katsushige ^b   Furusu, Akira ^b   Mishima, Yoko ^b   Harada, Takashi ^b   Ozono, Yoshiyuki ^b   Koji, Takehiko ^b   Kohno, Shigeru ^b  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Antisense oligonucleotides; HSP47; Peritoneal fibrosis

Indexed keywords

ALPHA ACTIN; ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; CHAPERONE; CHLORHEXIDINE GLUCONATE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; HEAT SHOCK PROTEIN 47; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELL INFILTRATION; COLLAGEN SYNTHESIS; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DISEASE COURSE; DRUG TARGETING; EXPERIMENTAL MODEL; FIBROSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MESOTHELIUM; MYOFIBROBLAST; NONHUMAN; PATHOPHYSIOLOGY; PERITONEUM FIBROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM; TISSUE SECTION;

EID: 0042432044     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00169.x     Document Type: Article

References (39)

1. AFTHENTOPOULS IE, PASSADAKIS P, OREOPOULOS DG: Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: One center's experience and review of the literature. Adv Ren Replace Ther 5:157-167, 1998
2. GANDHI VC, HUMAYUN HM, ING YS, et al: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140:1201-1203, 1980
3. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
4. COLES GA, TOPLEY N: Long-term peritoneal membrane changes. Adv Ren Replace Ther 7:289-301, 2000
5. SUGA H, TERAOKA S, OTA K, et al: Preventive effect of pirfenidone against experimental sclerosing peritonitis on rats. Exp Toxic Pathol 47:287-291, 1995
6. ISHII Y, SAWADA T, SHIMIZU A, et al: An experimental sclerosing encapsulating peritonitis model in mice. Nephrol Dial Transplant 16:1262-1266, 2001
7. SHIOSHITA K, MIYAZAKI M, OZONO Y, et al: Expression of heat shock protein 47 and 70 in the peritoneum of patients on continuous ambulatory peritoneal dialysis. Kidney Int 57:619-631, 2000
8. MISHIMA Y, MIYAZAKI M, ABE K, et al: Enhanced expression of heat shock protein 47 (HSP47) in rat model of peritoneal fibrosis. Perit Dial Int 23:14-22, 2003
9. NAKAI A, SATOH M, HIRAYOSHI K, NAGATA K: Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol 117:903-914, 1992
10. MASUDA H, FUKUMOTO M, HIRAYOSHI K, NAGATA K: Coexpression of the collagen-binding stress protein HSP47 gene and the α 1 (I) and α1 (III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 94:2481-2488, 1994
11. IWASHITA T, KADOTA J, NAITO S, et al: Involvement of collagen-binding heat shock protein 47 and procollagen type I synthesis in idiopathic pulmonary fibrosis: Contribution of type II pneumocytes to fibrosis. Hum Pathol 31:1498-1505, 2000
12. ABE K, OZONO Y, MIYAZAKI M, et al: Interstitial expression of heat shock protein 47 and α-smooth muscle actin in renal allograft failure. Nephrol Dial Transplant 15:529-535, 2000
13. MORIYAMA T, KAWADA N, ANDO A, et al: Up-regulation of HSP47 in the mouse kidneys with unilateral ureteral obstruction. Kidney Int 54:110-119, 1998
14. RAZZAQUE MS, TAGUCHI T: Collagen-binding heat shock protein (HSP) 47 expression in anti-thymocyte serum (ATS)-induced glomerulonephritis. J Pathol 183:24-29, 1997
15. RAZZAQUE MS, SHIMOKAWA I, NAZNEEN A, et al: Life-long dietary restriction modulates the expression of collagens and collagen-binding heat shock protein 47 in aged Fischer 344 rat kidney. Histochem J 31:123-132, 1999
16. CHENG M, RAZZAQUE MS, NAZNEEN A, TAGUCHI T: Expression of heat shock protein 47 in gentamicin-treated rat kidneys. Int J Exp Pathol 79:125-132, 1998
17. SAUK JJ, SMITH T, NORRIS K, FERREIRA L: Hsp 47 and the translation machinery cooperate in the production of α1 (I) chains of type I procollagen. J Biol Chem 269:3941-3946, 1994
18. SUNAMOTO M, KUZE K, TSUJI H, et al: Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis. Lab Invest 78:967-972, 1998
19. ABE K, MIYAZAKI M, KOJI T, et al: Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int 54:120-130, 1998
20. DE LEEUW WJ, SLAGBOOM PE, VIJG J: Quantitative comparison of mRNA levels in mammalian tissues: 28S ribosomal RNA level as an accurate internal control. Nucleic Acids Res 17:10137-10138, 1989
21. TSUKASAKI S, MIYAZAKI M, KOJI T, et al: Semi-quantitative non-radioactive in situ hybridization and its clinical application. Acta Histochem Cytochem 33:39-47, 2000
22. HORI Y, YAMADA K, HINAFUSA N, et al: Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int 56:2096-2106, 1999
23. KREDIET RT, ZWEERS MM, VAN DER WAL AC, STRUIJK DG: Neo-angiogengesis in the peritoneal membrane. Perit Dial Int 20(Suppl): S19-S25, 2000
24. DOBBIE JW: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 12:14-27, 1992
25. LO WK, CHAN KT, LEUNG AC, et al: Sclerosing peritonitis complicating prolonged use of chlorhexidine in alcohol in the connection procedure for continuous ambulatory peritoneal dialysis. Perit Dial Int 2:166-172, 1991
26. NAKAYAMA M, KAWAGUCHI Y, YAMADA K, et al: Immunohistochemical detection of advanced glycosylation end-products in the peritoneum and its possible pathophysiological role in CAPD. Kidney Int 51:182-186, 1997
27. MIYATA T, DEVUYST O, KUROKAWA K, et al: Toward better dialysis compatibility: Advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 61:375-386, 2002
28. KASHIHARA N, MAESHIMA Y, MAKINO H: Antisense oligonucleotides. Exp Nephrol 6:84-88, 1998
29. MARRA F, PASTACALDI S, ROMANELLI RG, et al: Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. FEBS Lett 414:221-225, 1997
30. GARCIA-VELASCO JA, SELI E, ARICI A: Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by integrin-dependent cell adhesion. Biol Reprod 61:548-552, 1999
31. TAMADA S, NAKATANI T, ASAI T, et al: Inhibition of nuclear factor-kappaB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy. Kidney Int 63:306-314, 2003
32. WADA T, FURUICHI K, SAKAI N, et al: Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 58:1492-1499, 2000
33. HONDA K, NITTA K, HORITA S, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
34. COMBET S, MIYATA T, MOULIN P, et al: Vascular proliferation and enhanced expression of endothelial nitric oxidase synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol 11:717-728, 2000
35. IRUELA-ARISPE ML, HASSELAAR P, SAGE H: Differential expression of extracellular proteins is correlated with angiogenesis in vitro. Lab Invest 64:174-186, 1991
36. SAGE H, VERSON RB: Regulation of angiogenesis by extracellular matrix: The growth and glue. J Hypertens 12(Suppl):S145-S152, 1994
37. IRUELA-ARISPE ML, DIGLIO CA, SAGE H: Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro. Arterioscler Thromb 11:805-815, 1991
38. GRANT DS, KLEINMAN HK, MARTIN GR: The role of basement membranes in vascular development. Ann N Y Acad Sci 588:61-72, 1990
39. MARGETTS PJ, GYORFFY S, KOLB M, et al: Angiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 13:721-728, 2002